The preclinical basis of the therapeutic evaluation of losartanTIMMERMANS, P. B. M. W. M; WONG, P. C; CHIU, A. T et al.Journal of hypertension. Supplement. 1995, Vol 13, Num 1, pp S1-S13, issn 0952-1178Article

Clinical pharmacology of the angiotensin II receptor antagonist losartan potassium in healthy subjectsBURNIER, M; WAEBER, B; BRUNNER, H. R et al.Journal of hypertension. Supplement. 1995, Vol 13, Num 1, pp S23-S28, issn 0952-1178Article

Changing approaches to cardiovascular careRODICIO, José L; SAFAR, Michel; ZANCHETTI, Alberto et al.Journal of hypertension. Supplement. 1995, Vol 13, Num 2, issn 0952-1178, 126 p.Conference Proceedings

Main objectives and new aspects of combination treatment of hypertensionWAEBER, B; BRUNNER, H. R.Journal of hypertension. Supplement. 1995, Vol 13, Num 2, pp S15-S19, issn 0952-1178Conference Paper

Practical relevance of the 24-hour trough : peak ratio of antihypertensive drugsFAIEZ ZANNAD.Journal of hypertension. Supplement. 1995, Vol 13, Num 2, pp S109-S112, issn 0952-1178Conference Paper

Putative mechanisms of cough after treatment with angiotensin converting enzyme inhibitorsSEMPLE, P. F.Journal of hypertension. Supplement. 1995, Vol 13, Num 3, pp S17-S21, issn 0952-1178Conference Paper

Clinical aspects of parathyroid hypertensive factorLEWANCZUK, R. Z; RESNICK, L. M; MEI-SHANG HO et al.Journal of hypertension. Supplement. 1994, Vol 12, Num 1, pp S11-S16, issn 0952-1178Conference Paper

Angiotensin converting enzyme inhibition and coronary artery diseasePEPINE, C. J.Journal of hypertension. Supplement. 1994, Vol 12, Num 4, pp S65-S71, issn 0952-1178Conference Paper

Co-expression of renin-angiotensin system component genes in human atrial tissueMORGAN, K; WHARTON, J; WEBB, J. C et al.Journal of hypertension. Supplement. 1994, Vol 12, Num 4, pp S11-S19, issn 0952-1178Conference Paper

Hemodynamic effects of inhibitors of the renin-angiotensin systemFOUAD-TARAZI, F. M.Journal of hypertension. Supplement. 1994, Vol 12, Num 2, pp S25-S29, issn 0952-1178Conference Paper

Involvement of angiotensin II and endothelin in matrix protein production and renal sclerosisRUIZ-ORTEGA, M; GOMEZ-GARRE, D; ALCAZAR, R et al.Journal of hypertension. Supplement. 1994, Vol 12, Num 4, pp S51-S58, issn 0952-1178Conference Paper

Randomly allocated study of the effects of standard therapy versus ACE inhibition on micro-albuminuria in essential hypertensionRUILOPE, L. M; LAHERA, V; ALCAZAR, J. M et al.Journal of hypertension. Supplement. 1994, Vol 12, Num 4, pp S59-S63, issn 0952-1178Conference Paper

The advantages of angiotensin II antagonismBURNIER, M; WAEBER, B; BRUNNER, H. R et al.Journal of hypertension. Supplement. 1994, Vol 12, Num 2, pp S7-S15, issn 0952-1178Conference Paper

Trough and peak effects of a single daily dose of nifedipine gastrointestinal therapeutic system (GITS) as assessed by ambulatory blood pressure monitoringZANCHETTI, A.Journal of hypertension. Supplement. 1994, Vol 12, Num 5, pp S23-S27, issn 0952-1178Conference Paper

Inter-relationships between hypertension, left ventricular hypertrophy and coronary heart diseaseDEVEREUX, R. B; ROMAN, M. J.Journal of hypertension. Supplement. 1993, Vol 11, Num 4, pp S3-S9, issn 0952-1178Article

Is it hyperinsulinemia or insulin resistance that is related to hypertension and other metabolic cardiovascular risk factors ?LIND, L; LITHELL, H; POLLARE, T et al.Journal of hypertension. Supplement. 1993, Vol 11, Num 4, pp S11-S16, issn 0952-1178Article

Is cardioprotection important in the treatment of hypertension ? Considerations for the ideal agentSLEIGHT, P.Journal of hypertension. Supplement. 1993, Vol 11, Num 4, pp S49-S53, issn 0952-1178Article

Quality of life as an outcome variable and a risk factor for total mortality and cardiovascular disease : a study of men born in 1913TIBBLIN, G; SVÄRDSUDD, K; WELIN, L et al.Journal of hypertension. Supplement. 1993, Vol 11, Num 4, pp S81-S86, issn 0952-1178Article

European Society of Hypertension. MeetingREID, John L.Journal of hypertension. Supplement. 1993, Vol 11, Num 5, issn 0952-1178Conference Proceedings

Bradykinin prevents left ventricular hypertrophy in ratsLINZ, W; WIEMER, G; SCHÖLKENS, B. A et al.Journal of hypertension. Supplement. 1993, Vol 11, Num 5, pp S96-S97, issn 0952-1178Conference Paper

Diurnal blood pressure rhythm and urinary catecholamine excretion in obstructive sleep apnoea and essential hypertensionLAPINSKI, M; PRZYBYLOWSKI, T; LEWANDOWSKI, J et al.Journal of hypertension. Supplement. 1993, Vol 11, Num 5, pp S292-S293, issn 0952-1178Conference Paper

Divergent responses of common carotid artery intimal-medial thickness to high blood pressure and hypercholesterolaemia in relation to ageLUDWIG, M. M; JÖRGER, U; LUND, S et al.Journal of hypertension. Supplement. 1993, Vol 11, Num 5, pp S130-S131, issn 0952-1178Conference Paper

Effect of cicaprost on the progression of diabetic nephropathy in uninephrectomized streptozotocin-induced diabetic ratsROBLES, R. G; VILLA, E; RABANO, A et al.Journal of hypertension. Supplement. 1993, Vol 11, Num 5, pp S208-S209, issn 0952-1178Conference Paper

Effects of blood pressure reduction with trandolapril and enalapril on left ventricular hypertrophy and exercise toleranceLEONETTI, G; FOGARI, R; MAZZOLA, C et al.Journal of hypertension. Supplement. 1993, Vol 11, Num 5, pp S356-S357, issn 0952-1178Conference Paper

Effects of fosinopril and hydrochlorothiazide on cerebral perfusion in uncomplicated essential hypertensionSEMPLICINI, A; SIMONELLA, C; MENEGHETTI, G et al.Journal of hypertension. Supplement. 1993, Vol 11, Num 5, pp S372-S373, issn 0952-1178Conference Paper